Guía práctica para la Atención de la Tuberculosis en niños, niñas adolescentes
Secretaria de Salud de México. 2011 Practical guide for tuberculosis care in children, adolescent girls. Secretary of Health of Mexico.
MaraisBJ, GieRP, HesselingAC, SchaafHS, LombardC, EnarsonDA, BeyersN, 2006. A refined symptom based approach to diagnose pulmonary tuberculosis in children. Pediatrics118:1350–1359.
MaraisBJGieRPHesselingACSchaafHSLombardCEnarsonDABeyersN, 2006. A refined symptom based approach to diagnose pulmonary tuberculosis in children. Pediatrics118:1350–1359.)| false
Secretaría de Salud
, 2017. Manual de Vacunación. Health Ministry. Vaccination manual.
JenkinsHE, TolmanAW, YuenCM, ParrJB, KeshavjeeS, Pérez-VélezCM, PaganoM, BecerraMC, CohenT, 2014. Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates. Lancet383:1572–1579.
JenkinsHETolmanAWYuenCMParrJBKeshavjeeSPérez-VélezCMPaganoMBecerraMCCohenT, 2014. Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates. Lancet383:1572–1579.)| false
HausteinT, RidoutDA, HartleyJC, ThakerU, ShingadiaD, KleinNJ, NovelliV, DixonGLJ, 2009. The likelihood of an indeterminate test result from a whole-blood interferon-gamma release assay for the diagnosis of Mycobacterium tuberculosis infection in children correlates with age and immune status. Pediatr Infect Dis J28:669–673.
HausteinTRidoutDAHartleyJCThakerUShingadiaDKleinNJNovelliVDixonGLJ, 2009. The likelihood of an indeterminate test result from a whole-blood interferon-gamma release assay for the diagnosis of Mycobacterium tuberculosis infection in children correlates with age and immune status. Pediatr Infect Dis J28:669–673.)| false
By P. B. Bhattacharya. Second Edition. Revised, Re-written, Enlarged and Brought Up to Date. By J. C. Banerjea, M.B. (Cal.), M.R.C.P. (Lond.) and P. B. Bhattacharya, M.B., D.T.M. (Cal.). Bengal Medical Service, Upper. Pp. I–X. 1–413. U. N Dhur & Co., Calcutta. 1938
by George Cheever Shattuck, M.D., Professor of Tropical Medicine, Emeritus, Harvard Medical School and School of Public Health. 803 pp., illustrated. Cloth. New York: Appleton-Century-Crofts, Ind. 1951. Price $10.00
Tuberculosis (TB) remains a global problem and a diagnostic challenge, especially in pediatrics. The aim of this study was to describe the clinical, microbiological, radiological, and histopathological data of TB in children. A 7-year retrospective and descriptive cohort study that included 127 patients under 18 years of age with diagnosis of active TB was conducted from 2011 to 2018 in a pediatric hospital. Tuberculosis was microbiologically confirmed using Ziehl–Neelsen (ZN) staining, culture or polymerase chain reaction (PCR) in a total of 94 (74%) cases. Thirty-three cases were defined as probable TB based on tuberculin skin test result and epidemiological evaluation. The TB forms found were lymph node (39.3%), bone (15.7%), lung (13.6%), and meningeal TB (8.6%). The most common symptoms were fever (48.8%) and adenopathy (45.6%). History of contact was established in 34.6%. Positive ZN staining (sensitivity 30%) and culture (sensitivity 37%) were found in 29% and 37.7% of subjects, respectively. About 64.5% depicted abnormal chest X-ray. Xpert MTB/RIF® (PCR) was positive in 9.4% and biopsy was compatible in 52.7% of these samples. It is fundamental to have laboratory and epidemiological evaluation that support the diagnosis of the disease in children and thus, define its management; since, in most cases, early microbiologic confirmation is lacking.
Address correspondence to Hugo Juárez Olguín, Laboratorio de Farmacología, Instituto Nacional de Pediatría, Avenida Imán N 1, 3rd piso Colonia Cuicuilco, CP 04530, Ciudad de Mexico. E-mail: firstname.lastname@example.org
Ethical approval and consent to participate: Ethics approbation and consent to participate was authorized by The Academic College of the National Institute of Pediatrics.
Authors’ addresses: Napoleón González Saldaña, Mercedes Macías Parra, and José Iván Castillo Bejarano, Department of Infectology, Instituto Nacional de Pediatria (INP), Mexico City, Mexico, E-mails: email@example.com, firstname.lastname@example.org, and email@example.com. Hugo Juárez Olguín, Department of Pharmacology, Instituto Nacional de Pediatria (INP), Mexico City, Mexico, and Department of Pharmacology, Faculty of Medicine, Universidad Nacional Autónoma de Mexico, Mexico City, Mexico, E-mail: firstname.lastname@example.org. Monica Punzo Soto and Francisca Trujillo Jimenez, Department of Pharmacology, Instituto Nacional de Pediatria (INP), Mexico City, Mexico, E-mails: email@example.com and firstname.lastname@example.org.